Atossa Therapeutics
ATOS
#9930
Rank
S$45.9 M
Marketcap
S$5.33
Share price
-4.75%
Change (1 day)
376.04%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -S$39.57 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$32.3 Million, an increase over its 2023 earnings that were of -S$38.11 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$39.57 Million22.53%
2024 -S$32.3 Million-15.25%
2023 -S$38.11 Million11.62%
2022 -S$34.14 Million30.84%
2021 -S$26.1 Million15.58%
2020 -S$22.58 Million3.41%
2019 -S$21.83 Million51.16%
2018 -S$14.45 Million40.41%
2017 -S$10.29 Million27.54%
2016 -S$8.07 Million-47.49%
2015 -S$15.36 Million-17.25%
2014 -S$18.56 Million35.91%
2013 -S$13.66 Million112.3%
2012 -S$6.44 Million46.53%
2011 -S$4.39 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.01 B-107,442.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
S$1.62 B-4,364.41%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$1.68 B-4,517.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
S$52.77 M-238.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-S$0.14 Billion 261.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-S$9.93 Million-74.02%๐Ÿ‡บ๐Ÿ‡ธ USA